Alzheimer’s Disease

Socially assistive robots & dementia

Mild cognitive impairment: biomarker counseling, diagnosis and follow-up

Post-COVID-19 dementia landscape

Diagnosing mild cognitive impairment

Alzheimer’s disease: what are the challenges when disease-modifying therapies become available?

Metabolic deficits and neuropsychological changes in Alzheimer’s disease

Dementia care during the COVID-19 pandemic

Is the world prepared for dementia?

Current diagnostic tools for Alzheimer’s disease

NLGN1: potential biomarker of Alzheimer’s disease

Neuroligin-1 is altered in Alzheimer’s disease

Benefits of early detection in Alzheimer’s disease

Spectroscopic techniques for non-invasive diagnosis of Alzheimer’s disease

The role of blood spectroscopy in the Alzheimer’s disease diagnostic process

Alzheimer’s disease diagnosis: blood spectroscopy in the clinical setting

Alzheimer’s disease outlook: sensitive diagnostic approaches & efficient treatments